The Interaction Between Appetite Hormones
NCT02094183 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58
Last updated 2014-07-08
Summary
Glucagon Like Peptide (GLP) -1 affects metabolic response corrected for weight change
Conditions
Interventions
- OTHER
-
GLP-1
GLP-1
- DIETARY_SUPPLEMENT
-
low calorie diet
low calorie diet
Sponsors & Collaborators
-
The Danish Medical Research Council
collaborator OTHER -
University of Copenhagen
lead OTHER
Principal Investigators
-
Jens Holst, DMSCi · University of Copenhagen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- Denmark
Study Locations
More Related Trials
-
Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism.
NCT00940134 ·Status: COMPLETED ·Phase: NA
-
The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects
NCT01579981 ·Status: COMPLETED ·Phase: NA
-
Investigating Glucose Metabolism of LEAP2 With Total-body PET/CT
NCT06254365 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
NCT06818292 ·Status: COMPLETED ·Phase: NA
-
Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?
NCT03954873 ·Status: COMPLETED ·Phase: NA
-
Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)
NCT03013296 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
NCT02082496 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying
NCT04651868 ·Status: COMPLETED ·Phase: NA
-
Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.
NCT00705952 ·Status: COMPLETED ·Phase: NA
-
Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism
NCT00999271 ·Status: COMPLETED
-
Effects of Oral vs Intravenous Glucose Administration on Novel Candidates of Energy Regulation
NCT04888325 ·Status: COMPLETED ·Phase: NA
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
Glucagon Modulation of Ghrelin Secretion
NCT00929812 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity
NCT06845033 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
NCT06194955 ·Status: COMPLETED ·Phase: NA
-
Gut Hormones and Bone Remodeling in Humans (KS-2)
NCT03573934 ·Status: COMPLETED ·Phase: NA
-
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
NCT07171723 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Effect of Liraglutide on the GIT
NCT04008290 ·Status: UNKNOWN ·Phase: PHASE4
-
Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)
NCT00862589 ·Status: COMPLETED ·Phase: NA
-
Investigation of GLP-2 Mechanism of Action (GA-8)
NCT03159741 ·Status: COMPLETED ·Phase: NA
-
Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
NCT00264199 ·Status: COMPLETED ·Phase: NA
-
Glucagon Resistance in Patients With NAFLD
NCT04042142 ·Status: COMPLETED ·Phase: NA
-
Gastrectomy, Eating Behaviour and GLP-1
NCT02971631 ·Status: COMPLETED ·Phase: NA
-
Effects of Gut Peptides on Bone Remodeling
NCT03574064 ·Status: COMPLETED ·Phase: NA
-
GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
NCT00716170 ·Status: COMPLETED